文献速递脊柱关节炎

人附着点髓系细胞是局部IL-23产生的主要来源

Identification of myeloid cells in the human enthesis as the main source of local IL-23 production.
PubMed 文献 · Ann Rheum Dis · 2019-04-24

研究正常人体脊柱附着点是否含驻留髓系细胞群,能产生TNF和IL-23,并评估PDE4抑制的影响。从附着点软组织及邻近骨分离出CD14+髓系细胞,该群是IL-23、IL-1β、TNF和CCL20的主要诱导产生者,PDE4抑制剂可下调IL-23和TNF。

要点

  • 人附着点含CD14+髓系细胞,是局部IL-23、IL-1β、TNF和CCL20的主要来源。
  • PDE4抑制剂及升高cAMP的药物可下调附着点CD14+细胞的IL-23和TNF。
  • 附着点CD14+细胞基因表达与匹配血CD14+细胞相似,但CCR2表达显著降低。

核心结论

  • 人附着点含CD14+髓系细胞群,产生大部分可诱导的IL-23、IL-1β、TNF和CCL20。
  • 该群基因表达谱与匹配血CD14+群相似,但CCR2基因表达显著降低。

研究设计与样本

  • 正常人体附着点软组织及邻近附着点骨(n=15)经免疫组化、消化做髓系细胞表型分析、分选并刺激。
  • 刺激物为脂多糖和甘露聚糖,分析IL-23全蛋白、TNF、IL-1β和CCL20的诱导产生。
  • 髓系群与匹配血群做mRNA分析比较,并评估PDE4抑制效果。

主要发现

  • 从软组织和邻近附着点骨分离出CD45+ HLADR+ CD14+ CD11c+表型,称「CD14+髓系细胞」,CD14+免疫组化确认组织定位。
  • CD14-组分含CD123+ HLADR+ CD11c-细胞群(浆细胞样树突状细胞)。
  • CD14+群是附着点IL-23、IL-1β、TNF和CCL20的主要产生者。
  • PDE4抑制剂及其他升高cAMP的药物(组胺和8-Bromo-cAMP)可下调CD14+群的IL-23和TNF。
  • 附着点CD14+细胞与匹配血CD14+群基因表达谱 broadly 相似,但CCR2基因表达显著降低。

关键数值与推荐

  • CD14+髓系细胞表型为CD45+ HLADR+ CD14+ CD11c+。
  • 浆细胞样树突状细胞表型为CD123+ HLADR+ CD11c-。

临床怎么用

  • 附着点驻留CD14+髓系细胞是脊柱关节炎相关炎症因子的局部来源,支持靶向IL-23及PDE4抑制的治疗策略。

局限性

  • 样本为正常人体附着点(n=15),未涉及脊柱关节炎患者组织。
  • 研究为体外刺激与表型分析,PDE4抑制效果未在临床结局中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated whether the normal human spinal enthesis contained resident myeloid cell populations, capable of producing pivotal proinflammatory cytokines including tumour necrosis factor (TNF) and interleukin (IL)-23 and determined whether these could be modified by PDE4 inhibition. METHODS: Normal human enthesis soft tissue (ST) and adjacent perientheseal bone (PEB) (n=15) were evaluated using immunohistochemistry (IHC), digested for myeloid cell phenotyping, sorted and stimulated with different adjuvants (lipopolysaccharide and mannan). Stimulated enthesis fractions were analysed for inducible production of spondyloarthropathy disease-relevant mediators (IL-23 full protein, TNF, IL-1β and CCL20). Myeloid populations were also compared with matched blood populations for further mRNA analysis and the effect of PDE4 inhibition was assessed. RESULTS: A myeloid cell population (CD45+ HLADR+ CD14+ CD11c+) phenotype was isolated from both the ST and adjacent PEB and termed 'CD14+ myeloid cells' with tissue localisation confirmed by CD14+ IHC. The CD14- fraction contained a CD123+ HLADR+ CD11c- cell population (plasmacytoid dendritic cells). The CD14+ population was the dominant entheseal producer of IL-23, IL-1β, TNF and CCL20. IL-23 and TNF from the CD14+ population could be downregulated by a PDE4I and other agents (histamine and 8-Bromo-cAMP) which elevate cAMP. Entheseal CD14+ cells had a broadly similar gene expression profile to the corresponding CD14+ population from matched blood but showed significantly lower CCR2 gene expression. CONCLUSIONS: The human enthesis contains a CD14+ myeloid population that produces most of the inducible IL-23, IL-1β, TNF and CCL20. This population has similar gene expression profile to the matched blood CD14+ population.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Bridgewood C, Watad A, Russell T, et al. Identification of myeloid cells in the human enthesis as the main source of local IL-23 production. Ann Rheum Dis. 2019. PMID: 31018959. doi:10.1136/annrheumdis-2018-214944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。